ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1528392
This article is part of the Research TopicCancer Biology, Immunotherapy and AgingView all 9 articles
A Machine Learning Model for Predicting Bone and/or Lung Metastasis in Differentiated Thyroid Carcinoma: Enhancing Precision in Risk Stratification
Provisionally accepted- Fujian Medical University Union Hospital, Fuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Differentiated thyroid cancer (DTC) incidence is rapidly rising worldwide. While most cases have a favorable prognosis, a subset of patients develop aggressive disease with distant metastases, particularly to the bone and lung, which significantly worsens outcomes. Current prediction models are limited in accuracy, often relying on basic clinical factors. This study aims to develop a machine learning model to improve prediction of bone and lung metastasis in DTC, enhancing risk stratification and early intervention. Methods: Using the SEER database, we developed several machine learning models-including XGBoost, Random Forest, Gradient Boosting Machine, Logistic Regression, Naive Bayes, and Classification and Regression Trees (CART)-to predict bone and lung metastasis risk in DTC patients. LASSO regression was applied to select key predictive variables, and SMOTE was used to address data imbalance. The model's generalizability was evaluated using an external validation cohort from China.Results: The XGBoost model demonstrated the highest performance, achieving an AUC of 0.988. Key predictive variables identified and included in the model were tumor size, radiation therapy, surgical interventions, histologic types, T and N stages, laterality, race, and household income. SHAP analysis confirmed the importance of these variables, with tumor size, radiation, and surgery emerging as primary predictors. In the external validation cohort, the model achieved an AUC of 0.866, indicating reliable predictive capability across clinical settings.This model accurately predicts bone and lung metastasis risk in DTC, offering valuable clinical utility for risk stratification and supporting early intervention strategies to improve outcomes in high-risk patients.
Keywords: thyroid cancer, bone metastasis, Lung metastasis, SEER, machine learning
Received: 14 Nov 2024; Accepted: 25 Aug 2025.
Copyright: © 2025 Huang, He, Chen and Liao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ru Chen, Fujian Medical University Union Hospital, Fuzhou, China
Shengyin Liao, Fujian Medical University Union Hospital, Fuzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.